Guangzhou Zhaoke Lian Fa Pharmaceutical

Zhaoke Ophthalmology is a leading ophthalmic pharmaceutical company in China, dedicated to the research, development, and commercialization of therapies for eye diseases. The company boasts a comprehensive pipeline covering both front-of-the-eye and back-of-the-eye conditions, including dry eye disease, glaucoma, and myopia. Its flagship product, COPIVIS (Cyclosporine A ophthalmic gel), is a major treatment for dry eye disease in the Chinese market. Zhaoke operates a state-of-the-art manufacturing facility in Guangzhou and maintains strategic partnerships with global biotech firms to expand its portfolio. The company was spun off from Lee's Pharmaceutical and is listed on the Hong Kong Stock Exchange. Its portfolio includes both innovative drugs and high-quality generics to address the significant unmet medical needs in the Chinese ophthalmic market.